Frontiers in Cardiovascular Medicine

Original Research

Published on 13 Oct 2022

Cardiovascular toxicity associated with angiogenesis inhibitors: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System database from 2014 to 2021

in Cardio-Oncology

YanFeng Wang
Chanjuan Cui
Xiayang Ren
Xinran Dong
Wei Cui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.988013

4,113 views
12 citations

Review

Published on 11 Oct 2022

Heart failure and cancer: From active exposure to passive adaption

in Cardio-Oncology

Yantao Du
Tao Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.992011

2,500 views
1 citation

Original Research

Published on 06 Oct 2022

Effect of radiotherapy on cardiac-specific death in patients with non-malignant tumors of central nervous system and related clinical features

in Cardio-Oncology

Ruxin Wang
Haowen Ye
Yongting Zhao
Li Ma
Jinjing Wei
Ying Wang
Xiaofang Zhang
Lihong Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.991621

1,462 views
1 citation

Case Report

Published on 06 Oct 2022

Immune myocarditis related to sintilimab treatment in a patient with advanced lung adenocarcinoma: A case report

in Cardio-Oncology

Yunling Lin
Xun Yuan
Lianglong Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.955527

2,864 views
8 citations

Opinion

Published on 30 Sep 2022

Ten step academic-industry digital health collaboration methodology: A case-based guide for digital health research teams with the example of cardio-oncology

in Cardio-Oncology

James MacLeod
Mohamed Abdelrahim
Sabrina Painter
Ragasnehith Maddula
Austin Steward
Abdulaziz Hamid
Richard K. Cheng
Vlad Zaha
Daniel Addison
Brenton Bauer

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.982059

3,659 views
4 citations

Case Report

Published on 30 Sep 2022

The surgical strategy of hormonally active primary cardiac paraganglioma sarcoma: A case report

in Cardio-Oncology

Xiangyu Wang
Haiyuan Liu
Shuaipeng Zhang
Shaojun Huang
Chengxin Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.941142

1,779 views

Case Report

Published on 29 Sep 2022

Overdrive pacing in the acute management of osimertinib-induced ventricular arrhythmias: A case report and literature review

in Cardio-Oncology

Yanyu Zhang
Xingtong Wang
Yilin Pan
Beibei Du
Kumaraswamy Nanthakumar
Ping Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.934214

3,049 views
8 citations

Original Research

Published on 29 Sep 2022

Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study

in Cardio-Oncology

Israa Fadhil Yaseen
Hasan Ali Farhan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.972455

3,662 views
6 citations

Opinion

Published on 29 Sep 2022

Leveraging innovation, education, and technology for prevention and health equity: Proceedings from the cardiology oncology innovation ThinkTank 2021

in Cardio-Oncology

Sherry-Ann Brown
Generika Berman
Jim Logan
Diego Sadler
Rohit Moudgil
Brijesh Patel
Marielle Scherrer-Crosbie
Daniel Addison
Richard K. Cheng
Arco J. Teske

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.982021

2,720 views
4 citations

Review

Published on 27 Sep 2022

Cardiac MRI assessment of anthracycline-induced cardiotoxicity

in Cardio-Oncology

Leila Mabudian
Jennifer H. Jordan
Wendy Bottinor
W. Gregory Hundley

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.903719

6,065 views
11 citations

Original Research

Published on 23 Sep 2022

Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?

in Cardio-Oncology

Xiongjun Peng
Yawen Zheng
Zhaowei Zhu
Na Liu
Shenghua Zhou
Junke Long

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.922095

2,446 views
3 citations

Clinical Trial

Published on 23 Sep 2022

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

in Cardio-Oncology

Quentin Jacquinot
Nathalie Meneveau
Antoine Falcoz
Malika Bouhaddi
Pauline Roux
Bruno Degano
Marion Chatot
Elsa Curtit
Laura Mansi
Marie-Justine Paillard

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1000846

4,732 views
15 citations

Case Report

Published on 23 Sep 2022

Case report: Evaluation of myocardial microcirculation in patients with breast cancer after anthracycline chemotherapy by using intravoxel incoherent motion imaging

in Cardio-Oncology

Shilan Li
Di Tian
Xin Li
Jia Li
Qingwei Song
Yunlong Xia
Zhiyong Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.900309

2,732 views
1 citation

Review

Published on 23 Sep 2022

Cardiovascular disease and chimeric antigen receptor cellular therapy

in Cardio-Oncology

Anjali Rao
Andrew Stewart
Mahmoud Eljalby
Praveen Ramakrishnan
Larry D. Anderson
Farrukh T. Awan
Alvin Chandra
Srilakshmi Vallabhaneni
Kathleen Zhang
Vlad G. Zaha

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.932347

5,321 views
11 citations

Review

Published on 23 Sep 2022

Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?

in Cardio-Oncology

Sabina Mędrek
Sebastian Szmit

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.984951

3,785 views
7 citations

Mini Review

Published on 21 Sep 2022

Cardiovascular effects of immunosuppression agents

in Cardio-Oncology

Aly Elezaby
Ryan Dexheimer
Karim Sallam

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.981838

14,663 views
53 citations